Literature DB >> 11588204

Cerebellar depolarization-induced suppression of inhibition is mediated by endogenous cannabinoids.

A C Kreitzer1, W G Regehr.   

Abstract

Depolarization of cerebellar Purkinje neurons transiently suppresses IPSCs through a process known as depolarization-induced suppression of inhibition (DSI). This IPSC suppression occurs presynaptically and results from an unknown retrograde signal released from Purkinje cells. We recorded IPSCs from voltage-clamped Purkinje cells in cerebellar brain slices to identify the retrograde signal for cerebellar DSI. We find that DSI persists in the presence of the broad-spectrum metabotropic glutamate receptor antagonist LY341495 and the GABA(B) receptor antagonist CGP55845, suggesting that the retrograde signal is not acting through these receptors. However, an antagonist of the cannabinoid CB1 receptor AM251 completely blocked cerebellar DSI. Additionally, the cannabinoid receptor agonist WIN55,212-2 suppressed IPSCs and occluded any additional IPSC reduction by DSI. These results indicate that cannabinoids released from Purkinje cells after depolarization activate CB1 receptors on inhibitory neurons and suppress IPSCs for tens of seconds. Cerebellar DSI thus shares a common retrograde messenger with DSI in the hippocampus and depolarization-induced suppression of excitation in the cerebellum, suggesting that retrograde synaptic suppression by endogenous cannabinoids represents a widespread signaling mechanism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11588204      PMCID: PMC6763870     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  109 in total

1.  Distinct endocannabinoid control of GABA release at perisomatic and dendritic synapses in the hippocampus.

Authors:  Sang-Hun Lee; Csaba Földy; Ivan Soltesz
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

2.  Are CB(1) Receptor Antagonists Nootropic or Cognitive Impairing Agents?

Authors:  Stephen A Varvel; Laura E Wise; Aron H Lichtman
Journal:  Drug Dev Res       Date:  2009-12-01       Impact factor: 4.360

3.  Dendritically released transmitters cooperate via autocrine and retrograde actions to inhibit afferent excitation in rat brain.

Authors:  Michiru Hirasawa; Yannick Schwab; Sirajedin Natah; Cecilia J Hillard; Ken Mackie; Keith A Sharkey; Quentin J Pittman
Journal:  J Physiol       Date:  2004-07-14       Impact factor: 5.182

4.  Presynaptic CB1 receptors regulate synaptic plasticity at cerebellar parallel fiber synapses.

Authors:  Megan R Carey; Michael H Myoga; Kimberly R McDaniels; Giovanni Marsicano; Beat Lutz; Ken Mackie; Wade G Regehr
Journal:  J Neurophysiol       Date:  2010-11-17       Impact factor: 2.714

5.  Mechanisms underlying input-specific expression of endocannabinoid-mediated synaptic plasticity in the dorsal cochlear nucleus.

Authors:  Yanjun Zhao; Maria Rubio; Thanos Tzounopoulos
Journal:  Hear Res       Date:  2011-03-21       Impact factor: 3.208

6.  Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy.

Authors:  Laxmikant S Deshpande; Sompong Sombati; Robert E Blair; Dawn S Carter; Billy R Martin; Robert J DeLorenzo
Journal:  Neurosci Lett       Date:  2006-11-15       Impact factor: 3.046

7.  Metabotropic suppression of excitation in murine autaptic hippocampal neurons.

Authors:  Alex Straiker; Ken Mackie
Journal:  J Physiol       Date:  2006-11-16       Impact factor: 5.182

8.  Central cannabinoid receptors modulate acquisition of eyeblink conditioning.

Authors:  Adam B Steinmetz; John H Freeman
Journal:  Learn Mem       Date:  2010-10-28       Impact factor: 2.460

9.  Kainate Receptors Inhibit Glutamate Release Via Mobilization of Endocannabinoids in Striatal Direct Pathway Spiny Projection Neurons.

Authors:  John J Marshall; Jian Xu; Anis Contractor
Journal:  J Neurosci       Date:  2018-03-14       Impact factor: 6.167

10.  Cannabinoids excite hypothalamic melanin-concentrating hormone but inhibit hypocretin/orexin neurons: implications for cannabinoid actions on food intake and cognitive arousal.

Authors:  Hao Huang; Claudio Acuna-Goycolea; Ying Li; H M Cheng; Karl Obrietan; Anthony N van den Pol
Journal:  J Neurosci       Date:  2007-05-02       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.